Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix® Spinal System
- Experienced MedTech leader to guide Amber Implants’ transition from development into commercialization following FDA clearance of the VCFix® Spinal System
- Company preparing for U.S. market launch in 2026
THE HAGUE, The Netherlands, Nov. 6, 2025 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the appointment of Vincent Gardès as Chief Executive Officer, effective immediately, following his four-year tenure as Chairman of the Board. This strategic leadership transition marks a significant milestone as Amber Implants moves from its development phase into commercialization, following the recent FDA clearance of the VCFix® Spinal System.
